The immunosuppressant 1,5-deoxyspergualin reveals commonality between PreT and PreB cell differentiation

Journal of Experimental Medicine

Volumn 183, Issue 6, 1996, Pages 2427-2436

  Wang, Bo ^a   Benoist, Christophe ^a,b   Mathis, Diane ^a,b  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b Inst Genet Biol Molec et Cell   (France)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GUANIDINE DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW; CELL MATURATION; GENE EXPRESSION; IMMUNOMODULATION; LYMPHOCYTE DIFFERENTIATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; B LYMPHOCYTE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; FETUS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; NONOBESE DIABETIC MOUSE; ORGAN CULTURE TECHNIQUE; PRENATAL DEVELOPMENT; T LYMPHOCYTE; THYMUS;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; B-LYMPHOCYTES; CELL DIFFERENTIATION; FETUS; FLOW CYTOMETRY; GUANIDINES; HEMATOPOIETIC STEM CELLS; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; ORGAN CULTURE TECHNIQUES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0030163998     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.6.2427     Document Type: Article

References (50)

1. Thomas, F.T., M.A. Tepper, J.M. Thomas, and C.E. Haisch. 1993. 15-deoxyspergualin: a novel immunosuppressive drug with clinical potential. Ann. N. Y. Acad. Sci. 685:175-192.
2. Tufveson, G., G. Gannedahl, C. Johnsson, M. Olausson, A. Wanders, and H. Ekberg. 1993. New immunosuppressants: testing and development in animal models and the clinic: with special reference to DSG. Immunol. Rev. 136:99-109.
3. Kerr, P.G., and R.C. Atkins. 1989. The effects of deoxyspergualin on lymphocytes and monocytes in vivo and in vitro. Transplantation. 48:1048-1057.
4. Jiang, H., S. Tatahara, Y. Takano, M. Machida, A. Iwasaki, Y. Kokado, H. Kameoki, M. Moutabarsik, and T. Sonoda. 1990. In vitro immunosuppressive effects of deoxyspergualin. Transplant. Proc. 22:1633-1637.
5. Fujii, H., T. Takada, N. Kyuichi, A. Fuminori, A. Fujii, J.E. Talmadge, and T. Takeuki. 1992. Deoxyspergualin, a novel immunosuppressant, markedly inhibits human mixed lymphocyte reaction and cytotoxic T lymphocyte activity in vitro. Int. J. Immunopharmacol. 14:731-737.
6. Takano, Y., S. Takahara, H. Jiang, Y. Kokado, H. Kameoka, A. Moutabarrik, M. Ishibashi, and A. Okuyama. 1992. Immunosuppressive mechanism of action of deoxymethylspergualin - A human in vitro assay. Transplant. Proc. 24:1372-1374.
7. Fugii, H., T. Takada, K. Nemoto, F. Abe, A. Fugii, and T. Takeushi. 1989. In vitro immunosuppressive properties of spergualins to murine T cell response. J. Antibiot. 42:788-792.
8. Nishimura, K., and T. Tokunaga. 1989. Effects of 15-deoxyspergualin on the induction of cytotoxic T lymphocytes and bone marrow suppression. Transplant. Proc. 21:1104-1107.
9. Morikawa, Z., F. Oseka, and S. Morikawa. 1992. The suppressive effect of deoxyspergualin on the differentiation of human B lymphocytes maturing into immunoglobulin-producing cells. Transplantation. 54:526-529.
10. Tepper, M.A., B. Petty, I. Bursuker, R.D. Pasternak, J. Cleaveland, G.L. Spitalny, and B. Schacter. 1991. Inhibition of antibody production by the immunosuppressive agent, 15-deoxyspergualin. Transplant. Proc. 23:328-334.
11. Leventhal, J.R., H.C. Flores, S.A. Gruber, J. Figueroa, J.L. Platt, J.C. Manivel, H. Bach, A.J. Matas, and R.M. Bolman. 1992. Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation. 54:26-32.
12. Alegre, M.L., H.A. Sattar, K.C. Herold, J. Smith, M.A. Tepper, and J.A. Bluestone. 1994. Prevention of the humoral response induced by an anti-CD3 monoclonal antibody by deoxyspergualin in a murine model. Transplantation. 57: 1794-1797.
13. Hoeger, P.H., M.A. Tepper, A. Faith, J.A. Higgins, J.R. Lamb, and R.S. Geha. 1994. Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes. J. Immunol. 153:3908-3916.
14. Nemoto, K., F. Abe, T. Nakamura, M. Ishizuka, T. Takeuchi, and H. Umezawa. 1987. Blastogenic responses and the release of interleukins 1 and 2 by spleen cells obtained from rat skin allograft recipients administered with 15-deoxyspergualin. J. Antibiot. 40:1062-1070.
15. Waaga, A.M., K. Ulrichs, M. Krzysmanski, J. Treumer, M.L. Hansmann, R. Rommel, and W. Müller-Ruchholtz. 1990. The immunosuppressive agent 15-deoxyspergualin induces tolerance and modulates MHC-antigen expression and interleukin-1 production in the early phase of rat allograft responses. Transplant. Proc. 22:1613-1614.
16. Takasu, S., K. Sakagami, F. Morisaki, T. Kawamura, M. Haisa, T. Oiwa, M. Inagaki, H. Hasuoka, Y. Kurozomi, and K. Orita. 1991. Immunosuppressive mechanism of 15-deoxyspergualin on sinusoidal lining cells in swine liver transplantation: suppression ot MHC class II antigens and interleukin-1 production. J. Surg. Res. 51:165-172.
17. Shinkai, Y., G. Rathbun, K.-P. Lam, E.M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A.M. Stall, and F.W. Alt. 1992. RAG-2 deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68:855-867.
18. Tomonari, K. 1988. A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics. 28:455-458.
19. Trowbridge, I.S., J. Lesley, R. Schuite, R. Human, and J. Trotter. 1982. Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphnode cells. Immunogenetics. 15:299-305.
20. + peripheral T cells. Cell. Immunol. 70:311-320.
21. Springer, T., G. Galfre, D.S. Secher, and C. Milstein. 1978. Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur. J. Immunol. 8:539-551.
22. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell. 66:1051-1066.
23. Chan, S.H., D. Cosgrove, C. Waltzinger, C. Benoist, and D. Mathis. 1993. Another view of the selective model of thymocyte selection. Cell. 73:225-236.
24. lo thymocytes: expression of CD44, CD25 and early expression of TcRα mRNA. Eur. J. Immunol. 23: 2109-2115.
25. Gilfillan, S., C. Waltzinger, C. Benoist, and D. Mathis. 1994. More efficient positive selection of thymocytes in mice lacking TdT. Internat. Immunol. 6:1681-1686.
26. Cardell, S., S. Tangri, S. Chan, M. Kronenberg, C. Benoist, and D. Mathis. 1995. CD1-restricted CD4+ T cells in MHC class II-deficient mice. J. Exp. Med. 182:993-1004.
27. Merkenschlager, M., C. Benoist, and D. Mathis. 1994. Evidence for a single-niche model of positive selection. Proc. Natl. Acad. Sci. USA. 91:11694-11698.
28. + T cells by TCR ligation without aggregation even in the absence of MHC. Nature (Lond.). 371:67-70.
29. - triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J. Immunol. 150:4244-4252.
30. Anderson, S.J., and R.M. Perlmutter. 1995. A signaling pathway governing early thymocyte maturation. Immunol. Today 16:99-105.
31. -/- mice in the absence of TCR β chain expression. Int. Immunol. 6:995-1001.
32. Jacobs, H., D. Vandeputte, L. Tolkamp, E. de Vries, J. Borst, and A. Berns. 1994. CD3 components at the surface of pro-T cells can mediate pre-T cell development in vivo. Eur. J. Immunol. 24:934-939.
33. Levelt, C., B. Wang, A. Ehrfeld, C. Terhorst, and K. Eichmann. 1995. Regulation of T cell receptor (TCR)-β locus allelic exclusion and initiation of TCR-α locus rearrangement in immature thymocytes by signaling through the CD3 complex. Eur J. Immunol. 25:1257-1261.
34. χ cytoplasmic domains can independently generate signals for T cell development and function. Immunity 2: 401-411.
35. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93-126.
36. Huesmann, M., B. Scott, P. Kisielow, and H. von Boehmer. 1991. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell. 66:533-540.
37. Lucas, B., F. Vasseur, and C. Penit. 1993. Normal sequence of phenotypic transitions in one cohort of 5-bromo-2′-deoxyuridine-pulse-labeled thymocytes. J. Immunol. 151:4574-4582.
38. Löffert, D., S. Schall, A. Ehlich, R.R. Hardy, Y.-R. Zou, W. Müller, and K. Rajewsky. 1994. Early B-cell development in the mouse: insights from mutations introduced by gene targeting. Immunol. Rev. 137:135.
39. Relink, A., H. Karasuyama, D. Haasner, U. Grawunder, I.-L. Martensson, A. Kudo, and F. Melchers. 1994. Two pathways of B-lymphocyte development in mouse bone marrow and the roles of surrogate L chain in this development. Immunol. Rev. 137:185.
40. Groettrup, M., A. Baron, G. Griffiths, R. Palacios, and H. von Boehmer. 1992. T cell receptor (TCR) β chain homodimers on the surface of immature but not mature α, γ, δ chain deficient T cell lines. EMBO (Eur. Mol. Biol. Organ.) J. 11: 2735-2746.
41. van Oers, N.S.C., and H. von Boehmer. 1995. The pre-T cell receptor (TCR) complex is functionally coupled to the TCR-ζ subunit J. Exp. Med. 182:1585-1590.
42. Negishi, I., N. Motoyama, K.-I. Nakayama, K. Nakayam, S. Senju, S. Hatakeyama, Q. Shang, A.C. Chan, and D.Y. Loh. 1995. Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature (Lond.). 376:435-438.
43. Matsuyama, T., T. Kimura, M. Kitagawa, K. Pfeffer, T. Kawakami, N. Watanabe, T.M. Küg, R. Amakawa, K. Kishihara, A. Wakeham et al. 1993. Targeted disruption of IRF-1 or 12 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell. 75:83-97.
44. Kishihara, K., J. Penninger, V.A. Wallace, T.M. Kündig, K. Kawai, A. Wakeham, E. Timms, K. Pfeffer, P.S. Ohashi, M.L. Thomas et al. 1993. Normal B lymphocyte development but impaired T cell maturation in CD45-exon 6 protein tyrosine phosphatase-deficient mice. Cell. 74:143-156.
45. Tepper, M.A., S.G. Nadler, J.M. Esselstyn, and K.G. Sterbenz. 1995. Deoxyspergualin inhibits κ light chain expression in 70Z/3 pre-B cells by blocking lipopolysaccharide-induced NF-κB activation. J. Immunol. 155:2427-2436.
46. Ivanov, V., M. Merkenschlager, and R. Ceredig. 1993. Antioxidant treatment of thymic organ cultures decreases NF-κB and TCF1 (α) transcription factor activities and inhibits αβ T cell development. J. Immunol. 151:4694-4701.
47. Peschon, J.J., P.J. Morrissey, K.H. Grabstein, F.J. Ramsdell, E. Maraskovsky, B.C. Gliniak, L.S. Park, S.F. Ziegler, D.E. Williams, C.B. Ware et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp.Med. 180:1955-1960.
48. Bhatia, S.K., L.T. Tygrett, K.H. Grabstein, and T.J. Waldschmidt. 1995. The effect of in vivo IL-7 deprivation on T cell maturation. J. Exp. Med. 181:1399-1409.
49. Rodewald, H.-R., K. Kretzschmar, W. Swat, and S. Takeda. 1995. Intrathymically expressed c-kit ligand (stem cell factor) is a major factor driving expansion of very immature thymocytes in vivo. Immunity 3:313-319.
50. Boismenu, R., M. Rhein, W.H. Fischer, and W.L. Havran. 1996. A role for CD81 in Early T cell development. Science (Wash. DC). 271:198-200.